Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kei Miyakawa

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Uirusu|December 1, 2024
[Characterization of SARS-CoV-2 variants using mini-gut organoids]Kei Miyakawa
Journal of Molecular Cell Biology|April 13, 2022
Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technologySundararaj Stanleyraj Jeremiah, Kei Miyakawa, Akihide Ryo
Vaccine|February 27, 2026
Immune response and IgG subclass dynamics following repeated SARS-CoV-2 mRNA vaccination in Japanese healthcare workersKaori Sano, Hideaki Kato, Akihide Ryo, et al.
The Journal of General Virology|November 15, 2008
Effects of the ligand sequence modifications on the retargeted transduction by the retroviral vector having a ligand-chimeric Env proteinKei Miyakawa, Rika Fujita, Masumi Katane, et al.
The Journal of Infectious Diseases|August 18, 2022
Enhancement of Humoral and Cellular Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 by a Third Dose of BNT162b2 Vaccine in Japanese Healthcare WorkersKei Miyakawa, Hideaki Kato, Norihisa Ohtake, et al.
Biochemical and Biophysical Research Communications|September 22, 2020
Potent antiviral effect of silver nanoparticles on SARS-CoV-2Sundararaj S Jeremiah, Kei Miyakawa, Takeshi Morita, et al.
Gastroenterology|May 2, 2022
Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in "Mini-gut" OrganoidsKei Miyakawa, Masakazu Machida, Tomoyuki Kawasaki, et al.
Advances in Experimental Medicine and Biology|March 31, 2026
Applications of Pseudoviruses Bearing Glycoproteins of SARS-CoV-2 and Influenza VirusMakoto Ota, Kaori Sano, Kenji Yoshihara, et al.
Autophagy|April 5, 2022
Crosstalk between the innate immune system and selective autophagy in hepatitis B virus infectionKei Miyakawa, Sundararaj Stanleyraj Jeremiah, Michinaga Ogawa, et al.
Future Microbiology|March 30, 2022
Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2Takahiko Koyama, Kei Miyakawa, Reitaro Tokumasu, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Uirusu|December 1, 2024
[Characterization of SARS-CoV-2 variants using mini-gut organoids]Kei Miyakawa
Journal of Molecular Cell Biology|April 13, 2022
Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technologySundararaj Stanleyraj Jeremiah, Kei Miyakawa, Akihide Ryo
Vaccine|February 27, 2026
Immune response and IgG subclass dynamics following repeated SARS-CoV-2 mRNA vaccination in Japanese healthcare workersKaori Sano, Hideaki Kato, Akihide Ryo, et al.
The Journal of General Virology|November 15, 2008
Effects of the ligand sequence modifications on the retargeted transduction by the retroviral vector having a ligand-chimeric Env proteinKei Miyakawa, Rika Fujita, Masumi Katane, et al.
The Journal of Infectious Diseases|August 18, 2022
Enhancement of Humoral and Cellular Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 by a Third Dose of BNT162b2 Vaccine in Japanese Healthcare WorkersKei Miyakawa, Hideaki Kato, Norihisa Ohtake, et al.
Biochemical and Biophysical Research Communications|September 22, 2020
Potent antiviral effect of silver nanoparticles on SARS-CoV-2Sundararaj S Jeremiah, Kei Miyakawa, Takeshi Morita, et al.
Gastroenterology|May 2, 2022
Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in "Mini-gut" OrganoidsKei Miyakawa, Masakazu Machida, Tomoyuki Kawasaki, et al.
Advances in Experimental Medicine and Biology|March 31, 2026
Applications of Pseudoviruses Bearing Glycoproteins of SARS-CoV-2 and Influenza VirusMakoto Ota, Kaori Sano, Kenji Yoshihara, et al.
Autophagy|April 5, 2022
Crosstalk between the innate immune system and selective autophagy in hepatitis B virus infectionKei Miyakawa, Sundararaj Stanleyraj Jeremiah, Michinaga Ogawa, et al.
Future Microbiology|March 30, 2022
Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2Takahiko Koyama, Kei Miyakawa, Reitaro Tokumasu, et al.
Pageof 9